Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Bain Capital Specialty Finance, Inc. today announced that it has priced an offering of $350 million 5.950% senior notes due 2030.

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

Bain Capital Specialty Finance , Inc. (NYSE:BCSF), a specialty finance company with a market capitalization of $1.17 billion and trading near its 52-week high of $18.35, announced the issuance of $350 ...

An affiliate of Bain Capital will acquire 51 per cent of the injection molding and extrusion machinery maker from current owner Hillenbrand Inc.

BRENTWOOD, Tenn. - Surgery Partners, Inc. (NASDAQ: NASDAQ:SGRY), a prominent operator of short-stay surgical facilities with ...

BOSTON--(BUSINESS WIRE)--Bain Capital Specialty Finance, Inc. (NYSE: BCSF or the “Company”) today announced that it has priced an offering of $350 million aggregate principal amount of 5.950% ...

Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...

Bain Capital Specialty Finance, Inc. (NYSE: BCSF or the “Company”) today announced that it has priced an offering of $350 million aggregate principal amount of 5.950% senior notes due 2030 ...

Surgery Partners received a non-binding acquisition proposal from Bain Capital for $25.75 per share, pending Board review. Surgery Partners, Inc. announced that its Board of Directors received a ...